FDA Class I Recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x… by Becton Dickinson & Company

Key facts

What this classification means

FDA classifies a recall as Class I when there is a reasonable probability that using the recalled product, or being exposed to it, will cause serious adverse health consequences or death. Class I is FDA's most serious recall classification. In this case, the recalling firm is Becton Dickinson & Company and the affected product is described in FDA's record as: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8.25%), 2 mL (marcaine). Catalog Number: 405671.. FDA's stated reason for the recall is: This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.. The recall is tracked under FDA recall number Z-2256-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do.

What consumers should do

Because FDA has assigned this recall its highest severity classification, anyone who has this product should stop using it immediately, regardless of whether a problem has been noticed yet. Specifically, check whether the product in your possession matches the description on file with FDA -- BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8.25%), 2 mL (marcaine). Catalog Number: 405671. -- and the recall number Z-2256-2026. If it matches, stop using or distributing it and contact Becton Dickinson & Company or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do.

Becton Dickinson & Company’s FDA history

Argus HQ has recorded 96 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 96 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

What was recalled and why?

Becton Dickinson & Company recalled BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8.25%), 2 mL (marcaine). Catalog Number: 405671.. FDA's record states the reason for recall as: This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.. The.

How serious is this recall?

FDA classifies a recall as Class I when there is a reasonable probability that using the recalled product, or being exposed to it, will cause serious adverse health consequences or death. Class I is FDA's most serious recall classification.

What should someone who has this product do?

Because FDA has assigned this recall its highest severity classification, anyone who has this product should stop using it immediately, regardless of whether a problem has been noticed yet. Check the product against FDA's description (BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) with dextrose (8.25%), 2 mL (marcaine). Catalog Number: 405671.) and recall number Z-2256-2026, then follow Becton Dickinson & Company's recall instructions.

Related enforcement actions

• Recall: Becton Dickinson & Company — Class II recall: 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk… →
• Recall: Becton Dickinson & Company — Class II recall: BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341; →
• Recall: Becton Dickinson & Co. — Class II recall: BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100; →
• Recall: Becton Dickinson & Co. — Class II recall: BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 Syst… →
• Recall: Becton Dickinson & Co. — Class II recall: BD Phoenix M50 Instrument, labeled as the following: 1. BD Phoenix M50 Automa… →
• Recall: Becton Dickinson & Co. — Class II recall: BD MAX System, for in vitro diagnostic (IVD) use, labeled as the following: 1… →
• Recall: Becton Dickinson & Co. — Class II recall: BD BACTEC Blood Culture System, labeled as the following: 1. BD BACTEC FX, In… →
• Recall: Becton Dickinson & Co. — Class II recall: BD Veritor Connect Software, labeled as the following: 1. Veritor (NUC), Cata… →